ivermectin for humans online Interest in raloxifene as a means for breast cancer prevention was renewed and resulted in FDA approval of raloxifene in 2007 for the treatment prevention of osteoporosis and for risk reduction of invasive breast cancer in postmenopausal women at high risk; 14 similar approval was given by the European Medicines Agency EMA in 2009